Here we demonstrated that the inhibition of Gal-1 by LLS30 suppressed T cell apoptosis, contributing the presence of TILs and consequently enhancing the effects of anti-PD1 immunotherapy to inhibit tumor growth. Here, LGALS1 is linked to neoplasm.